Protagonist presents one-year ICOTYDE psoriasis data at AAD meeting

March 28, 2026 10:05 AM

Protagonist Therapeutics Inc. (NASDAQ: PTGX) announced that one-year Phase 3 results for ICOTYDE (icotrokinra) were presented at the 2026 American ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found